Malladi Drugs & Pharmaceuticals IPO Details

Bookbuilding IPO | ₹[.] Cr | Listing at BSE, NSE |

Malladi Drugs & Pharmaceuticals Ltd. has opted for SEBI’s confidential pre-filing route and submitted its confidential Draft Red Herring Prospectus (DRHP) with SEBI on October 1, 2026 to raise funds through Initial Public Offer (IPO).

Malladi Drugs & Pharmaceuticals Ltd. IPO is a Book Build Issue

The equity shares are proposed to be listed on NSE and BSE. Axial Capital Pvt.Ltd. is the book running lead manager. Key details like IPO dates, IPO price bands and lot size are yet to be announced.

IPO Details

IPO Date	[.]
Listing Date	[.]
Face Value	₹[.] per share
Price Band
Sale Type	Fresh capital cum OFS
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE

IPO DRHP Status

Description	Date
Filed with SEBI/Exchange	Thu, Oct 1, 2026

About Malladi Drugs & Pharmaceuticals Ltd.

Established in 1980, Malladi Drugs & Pharmaceuticals Limited is a pharmaceutical company engaged in the research, development and manufacture of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company initially focused on the manufacture of Ephedrine and Pseudoephedrine salts and has expanded its capabilities through research-driven product development, regulatory expertise and modern manufacturing facilities.

Malladi Drugs & Pharmaceuticals operates three manufacturing facilities located in Tamil Nadu and Andhra Pradesh. Its products are supplied to pharmaceutical markets across more than 150 countries, with exports contributing around 85% of its revenue. The company has a team of more than 1,500 professionals supporting its manufacturing, research, quality and regulatory operations.

The company has filed and received approvals for 22 Drug Master Files (DMFs) from regulatory authorities including the USFDA, KFDA, CDSCO, PMDA, ANVISA and Health Canada. It also holds six Certificates of Suitability (CEPs) for key products, supporting the supply of its pharmaceutical products to regulated international markets.

Recently Listed IPOs in Pharmaceuticals

Company	Issue Type	Issue Size	Issue Price	PE Ratio	Listing Day Close	Listing Gain/Loss %	LTP
Symbiotec Pharmalab Ltd.	Mainboard	₹1,757.00 Cr	₹988	56.39	₹1,097.70	+11.10%	₹1,198.00
Hexagon Nutrition Ltd.	Mainboard	₹138.87 Cr	₹45	22.69	₹53.19	+18.20%	₹68.80
Sai Parenteral’s Ltd.	Mainboard	₹408.79 Cr	₹392	72.19	₹405.70	+3.49%	₹523.65

IPO Objects of the Issue

The Malladi Drugs & Pharmaceuticals Ltd. IPO is a 100% Offer for Sale (OFS), so the company will not receive any funding and the entire IPO proceeds will go to the selling shareholders.

IPO Lead Manager(s)

Axial Capital Pvt.Ltd.

Lead Manager Reports

Lead Manager Performance Summary
Lead Manager Performance Tracker

Contact Details

Malladi Drugs & Pharmaceuticals Ltd. Address

SKCL Tech Square,

7th Floor, Plot No. SP 14,

Thiru Vi Ka Industrial Estate, Guindy

Chennai, Tamil Nadu, 600032

44 6687 6900
info@malladi.co.in
Visit Website

IPO FAQs

What is the Malladi Drugs and Pharmaceuticals IPO?

Malladi Drugs and Pharmaceuticals IPO is a main-board IPO of 0 equity shares of the face value of ₹[.] aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .

The Malladi Drugs and Pharmaceuticals IPO open and close dates are not available as of now.

is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

How to apply in Malladi Drugs and Pharmaceuticals IPO through Angel One?

Angel One customers can apply online in Malladi Drugs and Pharmaceuticals IPO using UPI as a payment gateway. Angel One customers can apply in Malladi Drugs and Pharmaceuticals IPO by login into Angel One Console (back office) and submitting an IPO application form.

Steps to apply in Malladi Drugs and Pharmaceuticals IPO through Angel One

Visit the Angel One website and login to Console.
Go to Portfolio and click the IPOs link.
Go to the ‘Malladi Drugs and Pharmaceuticals IPO’ row and click the ‘Bid’ button.
Enter your UPI ID, Quantity, and Price.
Submit IPO application form.
Visit the UPI App (net banking or BHIM) to approve the mandate.
Visit Angel One IPO Application Process Review for more detail.

When Malladi Drugs and Pharmaceuticals IPO will open?

The Malladi Drugs and Pharmaceuticals IPO dates are not announced. Please check back again after some time.

What is the lot size of Malladi Drugs and Pharmaceuticals IPO?

Malladi Drugs and Pharmaceuticals IPO lot size and the minimum order quantity is not available at this time. Please check again later.

How to apply for Malladi Drugs and Pharmaceuticals IPO?

You can apply in Malladi Drugs and Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Angel One, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

When is Malladi Drugs and Pharmaceuticals IPO allotment?

The finalization of Basis of Allotment for Malladi Drugs and Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Malladi Drugs and Pharmaceuticals IPO allotment status.

When is Malladi Drugs and Pharmaceuticals IPO listing date ?

The Malladi Drugs and Pharmaceuticals IPO listing date is not yet announced. The tentative date of listing is .